Action of antiamoebic drugs on hepatic microsomal drug-metabolizing enzymes of hamster infected with virulent Entamoeba histolytica. 1983

V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao

UI MeSH Term Description Entries
D008101 Liver Abscess, Amebic Single or multiple areas of PUS due to infection by any ameboid protozoa (AMEBIASIS). A common form is caused by the ingestion of ENTAMOEBA HISTOLYTICA. Abscess, Amebic, Hepatic,Abscess, Hepatic, Amebic,Abscess, Liver, Amebic,Amebiasis, Hepatic,Entamoebiasis, Hepatic,Hepatic Amebiasis,Hepatic Entamoebiasis,Amoebiasis, Hepatic,Hepatic Abscess, Amoebic,Hepatic Amoebiasis,Liver Abscess, Amoebic,Abscess, Amebic Liver,Abscess, Amoebic Hepatic,Abscess, Amoebic Liver,Abscesses, Amebic Liver,Abscesses, Amoebic Hepatic,Abscesses, Amoebic Liver,Amebic Liver Abscess,Amebic Liver Abscesses,Amoebic Hepatic Abscess,Amoebic Hepatic Abscesses,Amoebic Liver Abscess,Amoebic Liver Abscesses,Entamoebiases, Hepatic,Hepatic Abscesses, Amoebic,Hepatic Entamoebiases,Liver Abscesses, Amebic,Liver Abscesses, Amoebic
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D004640 Emetine The principal alkaloid of ipecac, from the ground roots of Uragoga (or Cephaelis) ipecacuanha or U. acuminata, of the Rubiaceae. It is used as an amebicide in many different preparations and may cause serious cardiac, hepatic, or renal damage and violent diarrhea and vomiting. Emetine inhibits protein synthesis in EUKARYOTIC CELLS but not PROKARYOTIC CELLS. Ipecine,Methylcephaeline,Emetine Dihydrochloride,Emetine Hydrochloride,Dihydrochloride, Emetine,Hydrochloride, Emetine
D004748 Entamoeba histolytica A species of parasitic protozoa causing ENTAMOEBIASIS and amebic dysentery (DYSENTERY, AMEBIC). Characteristics include a single nucleus containing a small central karyosome and peripheral chromatin that is finely and regularly beaded. Endamoeba histolytica,histolytica, Endamoeba
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000563 Amebicides Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. Amoebicides
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao
March 1976, Indian journal of experimental biology,
V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao
July 1973, The Indian journal of medical research,
V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao
October 1981, Food and cosmetics toxicology,
V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao
August 1972, The Indian journal of medical research,
V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao
April 1983, Toxicology letters,
V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao
January 1988, Polish journal of pharmacology and pharmacy,
V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao
December 1972, Masui. The Japanese journal of anesthesiology,
V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao
March 1962, Biochemical pharmacology,
V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao
January 1973, Drug metabolism and disposition: the biological fate of chemicals,
V S Kumar, and P N Saxena, and L M Tripathi, and K C Saxena, and V K Mohan Rao
February 1975, Biochemical pharmacology,
Copied contents to your clipboard!